Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… AmBisome (amphotericin B) Liposome Injection, Fujisawa Healthcare, NDA 50-740/S14 9/16/03 9/25/03 9/26/03 AmBisome (amphotericin B) Liposome Injection Fujisawa Healthcare, NDA 50-740/S-001 1/28/00 11/20/01 11/20/01 11/20/01 AmBisome (amphotericin B) Liposome Injection Fujisawa Healthcare, NDA 50-740/S-002 AMPHOTERICIN B Cream; Topical 3% FUNGIZONE APOTHECON 050724 AMPHOTERICIN B Injectable, Lipid Complex; Injection 5MG/ML ABELCET ENZON 050729 AMPHOTERICIN B Injectable, Lipid Complex; Injection 100MG/VIAL AMPHOTEC INTERMUNE 050729 AMPHOTERICIN B Injectable, Lipid Complex; Injection 50MG/VIAL AMPHOTEC INTERMUNE 050740 AMPHOTERICIN B Injectable, Liposomal; Injection 50MG/VIAL AMBISOME FUJISAWA 060517 AMPHOTERICIN B Injection 50MG/VIAL FUNGIZONE APOTHECON 064062 AMPHOTERICIN B Injection 50MG/VIAL AMPHOTERICIN B Gensia Sicor 063206 AMPHOTERICIN B Injection 50MG/VIAL AMPHOTERICIN B TEK 060570 AMPHOTERICIN B Lotion; Topical 3% FUNGIZONE APOTHECON | AmBisome (amphotericin B) Liposome Injection, Astellas Pharma US, Inc., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com